(Q64221906)
Statements
A Phase IIa, Single-centre, Randomised, Vehicle Controlled, Double-blind Trial for Assessment of Efficacy, Safety and Tolerability of the Topical Formulation SB011 Containing a Human GATA-3 Specific DNAzyme and of Systemic Absorption of hgd40 Following Application to Lesional Skin in Patients With Atopic Eczema (English)
0 references
February 2014
0 references
November 2016
0 references
25
0 references
18 year
0 references
69 year
0 references